Showing results (1651-1660 of 1,739) with videos related to
Sort By:
Pageof 174
Neurosurgery|January 9, 2026
Using the Quality Outcomes Database to Identify Minimum Clinically Important Differences for Patients With Cervical Spondylotic MyelopathyAnthony L Asher, Nikita Lakomkin, Praveen V Mummaneni, et al.Neurosurgical Focus|May 1, 2026
Risk factors for persistent arm pain 5 years after surgery for cervical spondylotic myelopathy: a Spine CORe™ analysis of QOD dataNatasha Kharas, Graham Winston, Erica F Bisson, et al.Journal of Neurosurgery. Spine|April 6, 2023
Do comorbid self-reported depression and anxiety influence outcomes following surgery for cervical spondylotic myelopathy?Andrew K Chan, Christopher I Shaffrey, Christine Park, et al.Parasites & Vectors|December 6, 2019
Implementation of test-and-treat with doxycycline and temephos ground larviciding as alternative strategies for accelerating onchocerciasis elimination in an area of loiasis co-endemicity: the COUNTDOWN consortium multi-disciplinary study protocolSamuel Wanji, Theobald Mue Nji, Louise Hamill, et al.Journal of Neurosurgery. Spine|November 7, 2025
Impact of discharge to subacute rehabilitation or home with health services on prolonged length of stay and increased inpatient expense following elective surgery for cervical spondylotic myelopathy: a propensity score-matched Quality Outcomes Database studyHarrison J Howell, Farhan A Khan, Praveen V Mummaneni, et al.Journal of Neurosurgery. Spine|August 16, 2024
Predictors of patient satisfaction in the surgical treatment of cervical spondylotic myelopathyAlexander J Schupper, Joseph DiDomenico, S Harrison Farber, et al.Science Translational Medicine|June 28, 2023
Targeting CCR7-PI3Kγ overcomes resistance to tyrosine kinase inhibitors in ALK-rearranged lymphomaCristina Mastini, Marco Campisi, Enrico Patrucco, et al.Frontiers in Toxicology|May 4, 2026
New approach methodologies (NAMs) to support regulatory assessment of developmental immunotoxicity - a new PARC projectNicola M Smith, Véronique M P de Bruijn, Rob J Vandebriel, et al.Neurosurgical Focus|May 1, 2026
What are the predictors of prolonged length of stay following single-stage lumbar fusion for grade 2 spondylolisthesis? A Spine CORe™ analysis of QOD dataMichael D White, Izza Tahir, Maliya Delawan, et al.Journal of Neurosurgery. Spine|February 14, 2025
Does smoking status affect baseline symptom severity and patient-reported outcomes and satisfaction in patients with cervical myelopathy at 24 months? A Quality Outcomes Database studyChristine Park, Deb Bhowmick, Christopher I Shaffrey, et al.Pageof 174